CHRISTOPHER FORBES Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHRISTOPHER FORBES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHRISTOPHER FORBES. CHRISTOPHER FORBES is Director in Sevion Therapeutics, Inc. ($SVON).
Latest Insider Trading Transactions of CHRISTOPHER FORBES
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 1.05 | 16 | 17 | 2,026,021 | 2 M to 2 M (0.00 %) |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.99 | 325 | 322 | 2,026,021 | 2 M to 2 M (+0.02 %) |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.96 | 1,500 | 1,440 | 2,026,021 | 2 M to 2 M (+0.07 %) |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.95 | 1,000 | 950 | 2,026,021 | 2 M to 2 M (+0.05 %) |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.90 | 2,659 | 2,393 | 2,026,021 | 2 M to 2 M (+0.13 %) |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.89 | 399 | 355 | 2,026,021 | 2 M to 2 M (+0.02 %) |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.88 | 9,201 | 8,097 | 2,026,021 | 2 M to 2 M (+0.46 %) |
Mar 14 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.88 | 2,800 | 2,464 | 2,010,921 | 2 M to 2 M (+0.14 %) |
Mar 11 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.86 | 7,000 | 6,020 | 1,998,021 | 2 M to 2 M (+0.35 %) |
Mar 11 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.88 | 7,900 | 6,952 | 1,998,021 | 2 M to 2 M (+0.40 %) |
Mar 12 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.84 | 100 | 84 | 2,008,121 | 2 M to 2 M (0.00 %) |
Mar 12 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.88 | 10,000 | 8,800 | 2,008,121 | 2 M to 2 M (+0.50 %) |
Mar 11 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.84 | 550 | 462 | 1,983,121 | 2 M to 2 M (+0.03 %) |
Mar 07 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.86 | 9,800 | 8,428 | 1,982,571 | 2 M to 2 M (+0.50 %) |
Mar 07 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.85 | 10,000 | 8,500 | 1,982,571 | 2 M to 2 M (+0.51 %) |
Mar 06 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.81 | 500 | 405 | 1,962,771 | 2 M to 2 M (+0.03 %) |
Mar 06 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.84 | 11,900 | 9,996 | 1,962,771 | 2 M to 2 M (+0.61 %) |
Mar 03 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.79 | 900 | 711 | 1,950,371 | 1.9 M to 2 M (+0.05 %) |
Feb 29 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.78 | 100 | 78 | 1,949,471 | 1.9 M to 1.9 M (+0.01 %) |
Feb 27 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.78 | 5,000 | 3,900 | 1,949,371 | 1.9 M to 1.9 M (+0.26 %) |
Feb 27 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.77 | 200 | 154 | 1,949,371 | 1.9 M to 1.9 M (+0.01 %) |
Feb 27 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.75 | 9,000 | 6,750 | 1,949,371 | 1.9 M to 1.9 M (+0.46 %) |
Feb 27 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.74 | 1,000 | 740 | 1,949,371 | 1.9 M to 1.9 M (+0.05 %) |
Feb 26 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.80 | 100 | 80 | 1,934,171 | 1.9 M to 1.9 M (+0.01 %) |
Feb 26 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.79 | 2,100 | 1,659 | 1,934,171 | 1.9 M to 1.9 M (+0.11 %) |
Feb 26 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.78 | 2,800 | 2,184 | 1,934,171 | 1.9 M to 1.9 M (+0.14 %) |
Feb 26 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.76 | 5,000 | 3,800 | 1,934,171 | 1.9 M to 1.9 M (+0.26 %) |
Feb 25 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.79 | 17,000 | 13,430 | 1,924,171 | 1.9 M to 1.9 M (+0.89 %) |
Feb 25 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.78 | 5,900 | 4,602 | 1,924,171 | 1.9 M to 1.9 M (+0.31 %) |
Feb 25 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.77 | 400 | 308 | 1,924,171 | 1.9 M to 1.9 M (+0.02 %) |
Feb 22 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.80 | 20,000 | 16,000 | 1,900,871 | 1.9 M to 1.9 M (+1.06 %) |
Feb 22 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.75 | 18,300 | 13,725 | 1,900,871 | 1.9 M to 1.9 M (+0.97 %) |
Feb 20 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.75 | 6,450 | 4,838 | 1,862,571 | 1.9 M to 1.9 M (+0.35 %) |
Feb 20 2008 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.70 | 8,550 | 5,985 | 1,862,571 | 1.9 M to 1.9 M (+0.46 %) |
Dec 13 2007 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.94 | 146,000 | 136,598 | 1,782,571 | 1.6 M to 1.8 M (+8.92 %) |
Dec 17 2007 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 1.09 | 50,000 | 54,500 | 250,000 | |
Dec 17 2007 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.91 | 15,000 | 13,601 | 1,847,571 | 1.8 M to 1.8 M (+0.82 %) |
Dec 13 2007 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.95 | 50,000 | 47,500 | 1,832,571 | 1.8 M to 1.8 M (+2.80 %) |
Dec 12 2007 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.78 | 50,000 | 38,870 | 1,636,571 | 1.6 M to 1.6 M (+3.15 %) |
Dec 11 2007 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.54 | 54,000 | 28,928 | 1,586,571 | 1.5 M to 1.6 M (+3.52 %) |
Dec 18 2006 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 1.08 | 30,000 | 32,400 | 200,000 | |
Oct 13 2006 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 1.18 | 441,501 | 520,971 | 635,430 | |
Oct 13 2006 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Grant | A | 1.07 | 883,002 | 944,812 | 1,532,571 | 649.6 K to 1.5 M (+135.94 %) |
Mar 20 2006 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 1.50 | 40,000 | 60,000 | 649,569 | 609.6 K to 649.6 K (+6.56 %) |
Dec 16 2005 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 1.40 | 30,000 | 42,000 | 363,929 | |
Dec 20 2004 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 3.45 | 20,000 | 69,000 | 333,929 |
Page: 1